Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomesAnna V Christoforidou, Rima M Saliba, Patricia Williams, et al.British Journal of Haematology|September 12, 2008
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myelomaSundar Jagannath, Bart Barlogie, James R Berenson, et al.Cancer|March 26, 2011
Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapyValerie Reed, Jatin Shah, L Jeffery Medeiros, et al.Clinical Lymphoma, Myeloma & Leukemia|June 16, 2019
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell LeukemiaSamer Tabchi, Rajit Nair, Chutima Kunacheewa, et al.Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.Journal of Hematology & Oncology|June 3, 2014
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility studyM Kay Garcia, Lorenzo Cohen, Ying Guo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.The New England Journal of Medicine|June 27, 2003
A phase 2 study of bortezomib in relapsed, refractory myelomaPaul G Richardson, Bart Barlogie, James Berenson, et al.Pageof 3